|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 38/28 | (2006.01) |
| A61K 38/26 | (2006.01) | ||
| A61P 5/50 | (2006.01) |
| (11) | Number of the document | 3228320 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17169192.6 |
| Date of filing the European patent application | 2009-10-09 | |
| (97) | Date of publication of the European application | 2017-10-11 |
| (45) | Date of publication and mention of the grant of the patent | 2019-12-18 |
| (46) | Date of publication of the claims translation | 2020-03-10 |
| (30) | Number | Date | Country code |
| 102008051834 | 2008-10-17 | DE | |
| 102008053048 | 2008-10-24 | DE | |
| 102009038210 | 2009-08-20 | DE |
| (72) |
WERNER, Ulrich, DE
ROTTHÄUSER, Bärbel, DE
SMITH, Christopher, James, DE
|
| (73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Insulino ir GLP-1 agonisto derinys |
| COMBINATION OF AN INSULIN AND A GLP-1 AGONIST |
| Payment date | Validity (years) | Amount | |
| 2025-09-02 | 17 | 347.00 EUR |
| 2026-10-09 |